INOVIO PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
INOVIO PHARMACEUTICALS, INC. (INO) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $525.07 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-12
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $2.39M, a 10.44% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$1.86M.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$4.58M, a 629.34% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$350.13K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$6.42M.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$3.48M.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$45.99M, a 241.04% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $32.61M, a 24.73% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $525.07K 10-Q · filed 2026-08-12 | -$4.05M derived: sum of 3 quarters · filed 2026-08-12 | -$4.40M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | -$1.86M 10-Q · filed 2026-05-13 | -$6.44M derived: sum of 2 quarters · filed 2026-05-13 | -$6.79M derived: sum of 3 quarters · filed 2026-05-13 | -$4.12M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$4.93M derived: sum of 2 quarters · filed 2026-03-12 | -$2.26M derived: sum of 3 quarters · filed 2026-08-12 | -$6.42M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$350.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.31M derived: sum of 2 quarters · filed 2026-08-12 | -$1.85M 10-Q · filed 2025-11-10 | -$983.62K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$1.50M 10-Q · filed 2026-08-12 | -$633.49K derived: sum of 3 quarters · filed 2026-08-12 | -$2.61M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | -$4.16M 10-Q · filed 2026-05-13 | -$3.30M derived: sum of 2 quarters · filed 2026-05-13 | -$5.28M derived: sum of 3 quarters · filed 2026-05-13 | -$4.48M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $864.31K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.11M derived: sum of 2 quarters · filed 2026-03-12 | -$316.26K derived: sum of 3 quarters · filed 2026-03-12 | -$3.48M 10-K · filed 2026-03-12 | -$3.37M 10-K · filed 2025-03-18 | |||
| 2024-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.18M derived: sum of 2 quarters · filed 2025-11-10 | -$4.34M 10-Q · filed 2025-11-10 | $312.00K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $798.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$2.36M 10-Q · filed 2025-08-12 | $2.29M derived: sum of 3 quarters · filed 2025-08-12 | -$4.40M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$3.16M 10-Q · filed 2025-05-13 | $1.49M derived: sum of 2 quarters · filed 2025-05-13 | -$5.19M derived: sum of 3 quarters · filed 2025-05-13 | -$8.41M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$2.03M derived: sum of 2 quarters · filed 2025-03-18 | -$5.25M derived: sum of 3 quarters · filed 2025-03-18 | -$45.99M 10-K · filed 2025-03-18 | ||||
| 2023-09-30 | -$6.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$9.90M derived: sum of 2 quarters · filed 2024-11-14 | -$50.64M 10-Q · filed 2024-11-14 | -$45.36M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$3.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$43.96M 10-Q · filed 2024-08-08 | -$38.67M derived: sum of 3 quarters · filed 2024-08-08 | -$69.44M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$40.74M 10-Q · filed 2024-05-13 | -$35.46M derived: sum of 2 quarters · filed 2024-05-13 | -$66.22M derived: sum of 3 quarters · filed 2024-05-13 | $869.26K derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$25.48M derived: sum of 2 quarters · filed 2024-03-06 | $41.61M derived: sum of 3 quarters · filed 2024-03-06 | $32.61M 10-K · filed 2024-03-06 | ||||
| 2022-09-30 | -$30.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $36.32M derived: sum of 2 quarters · filed 2023-11-09 | $27.32M 10-Q · filed 2023-11-09 | $46.19M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2022-06-30 | $67.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $58.09M 10-Q · filed 2023-08-09 | $76.96M derived: sum of 3 quarters · filed 2024-03-06 | $74.21M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2022-03-31 | -$9.00M 10-Q · filed 2023-05-10 | -$9.86M 10-Q · filed 2022-05-10 | $9.87M derived: sum of 2 quarters · filed 2024-03-06 | $7.12M derived: sum of 3 quarters · filed 2024-03-06 | $12.41M derived: sum of 4 quarters · filed 2024-03-06 | |||
| 2021-12-31 | $18.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $16.12M derived: sum of 2 quarters · filed 2024-03-06 | $21.41M derived: sum of 3 quarters · filed 2024-03-06 | $26.14M 10-K · filed 2024-03-06 | $26.24M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.54M derived: sum of 2 quarters · filed 2022-11-08 | $7.27M 10-Q · filed 2022-11-08 | $7.42M 10-Q · filed 2021-11-09 | $5.14M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $5.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $10.02M 10-Q · filed 2022-08-09 | $8.89M 10-Q · filed 2021-08-09 | $7.89M derived: sum of 3 quarters · filed 2023-03-01 | $14.01M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | $4.74M 10-Q · filed 2022-05-10 | $2.60M derived: sum of 2 quarters · filed 2023-03-01 | $8.72M derived: sum of 3 quarters · filed 2023-03-01 | $15.20M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | -$2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $3.98M derived: sum of 2 quarters · filed 2023-03-01 | $10.47M derived: sum of 3 quarters · filed 2023-03-01 | $3.25M 10-K · filed 2023-03-01 | $3.12M 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $6.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $12.60M derived: sum of 2 quarters · filed 2021-11-09 | $5.38M 10-Q · filed 2021-11-09 | $13.84M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $6.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$732.77K 10-Q · filed 2021-08-09 | $7.72M derived: sum of 3 quarters · filed 2022-03-01 | $4.12M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | -$7.22M 10-Q · filed 2021-05-10 | $1.24M derived: sum of 2 quarters · filed 2022-03-01 | -$2.37M derived: sum of 3 quarters · filed 2022-03-01 | -$4.56M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $8.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.85M derived: sum of 2 quarters · filed 2022-03-01 | $2.66M derived: sum of 3 quarters · filed 2022-03-01 | -$4.34M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | -$3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$5.79M derived: sum of 2 quarters · filed 2020-11-09 | -$12.79M 10-Q · filed 2020-11-09 | -$7.35M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | -$2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$9.19M 10-Q · filed 2020-08-10 | -$3.75M derived: sum of 3 quarters · filed 2021-03-01 | $807.27K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | -$7.00M 10-Q · filed 2020-05-11 | -$1.56M derived: sum of 2 quarters · filed 2021-03-01 | $3.00M derived: sum of 3 quarters · filed 2021-03-01 | -$84.94K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $5.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $9.99M derived: sum of 2 quarters · filed 2021-03-01 | $6.91M derived: sum of 3 quarters · filed 2021-03-01 | $550.41K 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $4.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.48M derived: sum of 2 quarters · filed 2019-11-12 | -$4.89M 10-Q · filed 2019-11-12 | -$3.18M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | -$3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$9.44M 10-Q · filed 2019-08-08 | -$7.73M derived: sum of 3 quarters · filed 2020-03-12 | -$2.31M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | -$6.36M 10-Q · filed 2019-05-09 | -$4.65M derived: sum of 2 quarters · filed 2020-03-12 | $771.16K derived: sum of 3 quarters · filed 2020-03-12 | $2.11M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $7.13M derived: sum of 2 quarters · filed 2020-03-12 | $8.47M derived: sum of 3 quarters · filed 2020-03-12 | $2.83M 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | $5.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $6.76M derived: sum of 2 quarters · filed 2018-11-08 | $1.12M 10-Q · filed 2018-11-08 | $4.54M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$4.31M 10-Q · filed 2018-08-07 | -$886.25K derived: sum of 3 quarters · filed 2019-03-12 | $2.31M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-03-31 | -$5.64M 10-Q · filed 2018-05-09 | -$2.22M derived: sum of 2 quarters · filed 2019-03-12 | $971.92K derived: sum of 3 quarters · filed 2019-03-12 | $2.35M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2016-12-31 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $6.61M derived: sum of 2 quarters · filed 2019-03-12 | $7.99M derived: sum of 3 quarters · filed 2019-03-12 | $6.37M 10-K · filed 2019-03-12 | ||||
| 2016-09-30 | $3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $4.57M derived: sum of 2 quarters · filed 2017-11-08 | $2.95M 10-Q · filed 2017-11-08 | $7.01M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2016-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$247.01K 10-Q · filed 2017-08-08 | $3.82M derived: sum of 3 quarters · filed 2018-03-14 | $6.71M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2016-03-31 | -$1.62M 10-Q · filed 2017-05-10 | $2.44M derived: sum of 2 quarters · filed 2018-03-14 | $5.34M derived: sum of 3 quarters · filed 2018-03-14 | $6.82M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2015-12-31 | $4.07M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $6.96M derived: sum of 2 quarters · filed 2018-03-14 | $8.44M derived: sum of 3 quarters · filed 2018-03-14 | $6.46M 10-K · filed 2018-03-14 | ||||
| 2015-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $4.38M derived: sum of 2 quarters · filed 2016-11-09 | $2.39M 10-Q · filed 2016-11-09 | $3.33M 10-Q · filed 2015-11-09 | $4.29M derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2015-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$505.05K 10-Q · filed 2016-08-08 | $34.01K 10-Q · filed 2015-08-10 | $1.39M derived: sum of 3 quarters · filed 2017-03-15 | $396.23K derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2015-03-31 | -$1.99M 10-Q · filed 2016-05-09 | -$2.73M 10-Q · filed 2015-05-11 | -$90.02K derived: sum of 2 quarters · filed 2017-03-15 | -$1.09M derived: sum of 3 quarters · filed 2017-03-15 | -$1.13M derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2014-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $901.27K derived: sum of 2 quarters · filed 2017-03-15 | $852.34K derived: sum of 3 quarters · filed 2017-03-15 | $925.82K 10-K · filed 2017-03-15 | $1.49M 10-K · filed 2015-03-16 | |||
| 2014-09-30 | -$995.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$1.04M derived: sum of 2 quarters · filed 2015-11-09 | -$970.89K 10-Q · filed 2015-11-09 | $360.78K derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-06-30 | -$48.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $24.55K 10-Q · filed 2015-08-10 | $1.36M derived: sum of 3 quarters · filed 2016-03-14 | $1.67M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-03-31 | $73.48K 10-Q · filed 2015-05-11 | $1.41M derived: sum of 2 quarters · filed 2016-03-14 | $1.72M derived: sum of 3 quarters · filed 2016-03-14 | $2.02M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2013-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $1.64M derived: sum of 2 quarters · filed 2016-03-14 | $1.94M derived: sum of 3 quarters · filed 2016-03-14 | $2.12M 10-K · filed 2016-03-14 | $2.16M 10-K · filed 2014-03-17 | |||
| 2013-09-30 | $310.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $612.05K derived: sum of 2 quarters · filed 2014-11-10 | $792.10K 10-Q · filed 2014-11-10 | $861.48K derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-06-30 | $301.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $481.26K 10-Q · filed 2014-08-11 | $550.64K derived: sum of 3 quarters · filed 2015-03-16 | $385.41K derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-03-31 | $180.04K 10-Q · filed 2014-05-12 | $249.43K derived: sum of 2 quarters · filed 2015-03-16 | $84.20K derived: sum of 3 quarters · filed 2015-03-16 | $676.96K derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2012-12-31 | $69.39K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$95.84K derived: sum of 2 quarters · filed 2015-03-16 | $496.91K derived: sum of 3 quarters · filed 2015-03-16 | -$790.84K 10-K · filed 2015-03-16 | ||||
| 2012-09-30 | -$165.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $427.53K derived: sum of 2 quarters · filed 2013-11-12 | -$860.23K 10-Q · filed 2013-11-12 | $415.20K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | $592.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$695.00K 10-Q · filed 2013-08-09 | $580.44K derived: sum of 3 quarters · filed 2014-03-17 | $1.01M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | -$1.29M 10-Q · filed 2013-05-10 | -$12.32K derived: sum of 2 quarters · filed 2014-03-17 | $421.14K derived: sum of 3 quarters · filed 2014-03-17 | $982.34K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $1.71M derived: sum of 2 quarters · filed 2014-03-17 | $2.27M derived: sum of 3 quarters · filed 2014-03-17 | $1.79M 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | $433.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $994.66K derived: sum of 2 quarters · filed 2012-11-07 | $513.94K 10-Q · filed 2012-11-07 | $726.16K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | $561.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $80.48K 10-Q · filed 2012-08-09 | $292.69K derived: sum of 3 quarters · filed 2013-03-18 | $847.22K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | -$480.73K 10-Q · filed 2012-05-09 | -$268.51K derived: sum of 2 quarters · filed 2013-03-18 | $286.02K derived: sum of 3 quarters · filed 2013-03-18 | |||||
| 2010-12-31 | $212.22K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $766.74K derived: sum of 2 quarters · filed 2013-03-18 | -$156.07K 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | $554.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$368.29K 10-Q · filed 2011-11-07 | ||||||
| 2010-06-30 | -$922.82K 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | -$1.04M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |